Daily non-political popular news in brief.

Head and neck cancer vaccine targets proteins to create immune response

Researchers at the University of Pittsburgh Cancer Institute, in collaboration with the Gunma University School of Medicine in Japan, have developed a vaccine strategy for head and neck cancer that targets multiple peptides to activate the immune system to attack tumors. Their findings will be included in a press briefing on cancer vaccines at the annual meeting of the American Association for Cancer Research, April 14-18, at the Los Angeles Convention Center.

Read more »

Keywords: head, neck, cancer, vaccine, targets, proteins, create, immune, response, target, protein

« Previous | Next »

Similar news on "Head and neck cancer vaccine targets proteins to create immune response":

1. Novel vaccine concept developed by scientists at the Wistar Institute
   01-31-2008 · EurekAlert!
   A new vaccine design strategy developed by scientists at the Wistar Institute could help to develop vaccines against diseases like AIDS and cervical cancer. The secret is using a herpes simplex protein called glycoprotein D to block a receptor molecule on antigen-presenting cells. Wistar scientists showed that vaccine vectors made by fusing glycoprotein D with genes from HIV and HPV antigens increase the immune system's response to those antigens in cell cultures and mice.
   Similar news · Read more »
   
2. JCI table of contents: Dec. 13, 2007
   12-13-2007 · EurekAlert!
   This release contains summaries, links to PDFs, and contact information for the following newsworthy papers to be published online, Dec. 13, 2007, in the JCI: Treatment with SN reduces injury to the brain following stroke; OutRAGEd by atherosclerosis; A Neu protein target in the treatment of breast cancers; The long and winding TRAIL to cancer; Stressed-out hearts put MEF2D to work; How an antibody makes the CD4+ T cell immune response more aggressive; and others.
   Similar news · Read more »
   
3. Signal protein shows promise for blocking tumor promoters in skin cells
   11-03-2006 · EurekAlert!
   A protein with the ironic name "Srcasm" can counteract the effects of tumor-promoting molecules in skin cells. Using animal models, the researchers discovered that Srcasm acts like a brake in epithelial cells, preventing uncontrolled cell growth caused by a family of proteins called Src kinases. This finding, published online in the Journal of Biological Chemistry, suggests a target for future gene therapy to treat skin, head, neck, colon and breast cancers.
   Similar news · Read more »
   
4. Resisting lung cancer recurrence
   02-04-2008 · EurekAlert!
   What if we could prevent cancer recurrence for years after surgery by giving simple recall injections every two or three years? This concept may no longer be a fantasy. In a clinical study published online this week by the Proceedings of the National Academy of Science, a team headed by the international Ludwig Institute for Cancer Research has shown that a vaccine against a protein found in cancer cells produces an immune response that can be boosted and strengthened with additional vaccine shots.
   Similar news · Read more »
   
5. Saving salivary glands from the collateral damage of radiation therapy
   10-27-2006 · EurekAlert!
   Researchers have shown that targeted overexpression of heat shock protein 25 prevents radiation-induced damage to salivary glands, a common consequence of treatment for head and neck cancer. The related report by Lee et al., "Radioprotective effect of HSP25 on submandibular glands of rats," appears in the November issue of the American Journal of Pathology.
   Similar news · Read more »
   
6. JCI table of contents: July 12, 2007
   07-12-2007 · EurekAlert!
   This release contains summaries, links to PDFs and contact information for the following newsworthy papers to be published online, July 12, 2007, in the JCI, including: "Src inhibitors may prove beneficial in breast cancer therapy"; "The clot thickens: protein interaction is a drug target for blood clot prevention"; "Eap1 in the brain regulates the female reproductive cycle"; and "Which T cell types drive the autoimmune response in multiple sclerosis?"
   Similar news · Read more »
   
7. Overactive nerves in head and neck may account for 'ringing in the ears'
   01-10-2008 · EurekAlert!
   Baby boomers know all too well that "ringing in the ears" often comes with aging and hearing loss. Tinnitus can be the buzz that somatosensory neurons from the head and neck, like too many phone callers, create when they overcompensate for lost auditory signals from the ear, an animal study suggests. This nimble response to hearing loss, in which neurons adapt to changed conditions, is an example of the brain's "plasticity."
   Similar news · Read more »
   
8. Glue inside the cell
   10-19-2007 · EurekAlert!
   Ubiquitin is a small protein, which can be attached to other cellular proteins. A study headed by the Junior Group of Dr. Daniel Krappmann (GSF - National Research Center for Environment and Health, Institute of Toxicology) in collaboration with Dr. Jürgen Ruland (TU Munich) and Dr. Claus Scheidereit (Max-Delbrück-Center , Berlin) now reports a novel finding about ubiquitination as a key event for the activation of an immune response.
   Similar news · Read more »
   
9. Immune response to cancer stem cells may dictate cancer's course
   03-26-2007 · EurekAlert!
   Mounting evidence shows that a tumor's growth and spread may depend on "cancer stem cells," which comprise only a very small subset of the tumor. A new study by Rockefeller University scientists shows that immunity to cancer stem cells may help protect people with a precancerous condition from developing the full-blown disease, and that these cells could be an important target for cancer vaccines.
   Similar news · Read more »
   
10. Smoking does not lead to more aggressive or advanced breast cancers
    10-28-2007 · EurekAlert!
    Smoking cigarettes is associated with an increased risk of cancers of the lung, head and neck, esophagus, bladder and many others and also affects response to anti-cancer treatments. But smoking does not result in more advanced stage diagnoses or aggressive breast cancers at the time of diagnosis. That is the result of an analysis of 35 years of data for more than 6,000 patients.
    Similar news · Read more »